Skip to main content

Table 2 Effect of DOX and/or AHE treatment on body weight, heart weight and heart /body weight ratio of rats

From: Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats

Treatment (mg/kg)

Body weight (BW)(g)

Heart weight (HW)(g)

Ratio (HW/BWx103)

Initial

Final

  

Control

219.0 ± 0.577

250.3 ± 0.333b

0.501 ± 0.023

2.00

DOX

221.3 ± 0.667

226.3 ± 0.661a

0.76 ± 0.021a

3.35

AHE alone

220.3 ± 0.667

248.3 ± 0.671b

0.509 ± 0.01b

2.04

DOX + AHE (200)

221.7 ± 0.882

232.2 ± 0.611a,b

0.651 ± 0.019a**b*c**

2.80

DOX + AHE (400)

220.3 ± 0.882

244.7 ± 0.882a,b,c

0.534 ± 0.017b

2.18

DOX + Sily

222.0 ± 0.577

243.3 ± 0.333a,b

0.541 ± 0.018b

2.22

  1. Data expressed as mean ± SEM (n = 6)
  2. asignificant difference of final body weight of group Vs. Control group at p < 0.0001
  3. bsignificant difference of final body weight of group Vs. DOX-treated group at p < 0.0001
  4. csignificant difference of final body weight of DOX + AHE (200 mg/kg) treated group Vs. DOX + AHE (400 mg/kg) treated group at p < 0.001
  5. *, **indicate significance at p < 0.05 and p < 0.001. Non-significant difference (p > 0.05) was recorded between control and AHE alone treated group in all parameters. (One way ANOVA followed by Tukey’s multiple comparison tests). Sily-Silymarin